SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is hovering near the critical 80,000 resistance level as investors debate whether current institutional demand and supply scarcity will fuel a breakout or if the asset is facing a bull trap. Community discourse remains sharply divided between long-term holders expecting a major supply shock and skeptical traders who are closely watching for potential liquidations and volatility.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is experiencing high social volume as investors debate the impact of the upcoming Goliath Mainnet launch and its potential for enterprise adoption. While supporters point to staking rewards and technical infrastructure as catalysts for a rebound, skeptics remain vocal, citing lack of confirmed partnerships and historical price volatility as key concerns.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing massive momentum and high-volume trading driven by increasing investor confidence in its role within the AI optical interconnect sector, with many community members pointing to potential hyperscaler connections as a major catalyst. Despite significant short-seller skepticism, the stock has experienced a strong upward surge, fueling active debate between those anticipating a sustained breakout and others warning of a speculative bubble.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing significant community debate as investors speculate on potential price action linked to community-driven holidays and broader market correlations. Participants are actively weighing long-term optimism against technical frustration, with many debating if the asset is currently undervalued compared to its historical patterns or if it remains stagnant.

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

The FEFE community is actively promoting its role as the 'third frog' in Matt Furie's universe, positioning itself as a core component of the broader frog-themed memecoin narrative alongside PEPE and HOPPY. Investors are emphasizing the token's resilience and organic growth, rallying around its status as a community-led project during broader market volatility.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is facing downward pressure as investors react to soft quarterly guidance and concerns regarding memory chip supply constraints impacting smartphone production. Despite the near-term sell-off, the community is actively debating the stock's long-term value, highlighting its strategic growth in automotive, edge AI, and data center opportunities as potential catalysts for a recovery.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently surging due to a critical clinical trial milestone, with investors closely watching the upcoming Phase 3 readout for its gene-editing therapy and the implications for the broader biotech sector. The community is actively debating the stock's high short interest and potential for a squeeze against the backdrop of significant regulatory de-risking and positive long-term clinical data.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF is experiencing intense volatility and record-breaking momentum, fueled by aggressive AI infrastructure investment and heavy institutional liquidity despite broader geopolitical anxieties. While the community remains sharply divided, active discussions are centered on whether this vertical move represents a sustainable long-term structural shift or a classic speculative bubble ripe for a major reversal.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is trending as traders speculate on a potential price rebound, with the community actively debating whether it is an undervalued AI-integrated infrastructure project or a volatile asset prone to pump-and-dump cycles. Investors are closely monitoring its price correlation with other altcoins while analyzing wallet activity and historical chart patterns in hopes of triggering a significant rally.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is capturing significant investor attention as the community debates whether recent collaborative developments with major semiconductor entities will finally trigger the company's long-awaited commercial transition. While some investors are bullish on the technical potential of Atomera's proprietary material technology to solve critical power and performance bottlenecks, others remain skeptical due to the lack of material revenue and concerns over past performance.

statis crypto Watchlist

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 Whitehawk Therapeutics Presents Comprehensive Preclinical Data...

Insider Selling: Whitehawk Therapeutics (NASDAQ:WHWK) CFO Sells 77,000 Shares of Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CFO Scott Giacobello sold 77,000 shares of the business's stock in a transaction that occurred on Wednesday, April 15th. The stock was...

Whitehawk Therapeutics (NASDAQ:WHWK) CFO Scott Giacobello Sells 141,600 Shares

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CFO Scott Giacobello sold 141,600 shares of Whitehawk Therapeutics stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $4.13, for a total transaction of $584,808.00. Following the completion of the...

Scott Giacobello Sells 77,000 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CFO Scott Giacobello sold 77,000 shares of the company's stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $3.86, for a total transaction of $297,220.00. Following the completion of the...

Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series

Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series PR Newswire MORRISTOWN...

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Given Consensus Rating of "Hold" by Analysts

Shares of Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) have been assigned a consensus rating of "Hold" from the five analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three h...

Insider Selling: Whitehawk Therapeutics (NASDAQ:WHWK) Insider Sells 26,389 Shares of Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) insider Bryan Ball sold 26,389 shares of the business's stock in a transaction on Monday, April 13th. The shares were sold at an average...

Bryan Ball Sells 92,460 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) insider Bryan Ball sold 92,460 shares of the company's stock in a transaction on Tuesday, April 14th. The stock was sold at an average price of $3.64, for a total value of $336,554.40. Following the sale, the insider directly owned...

Bryan Ball Sells 26,389 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) insider Bryan Ball sold 26,389 shares of Whitehawk Therapeutics stock in a transaction dated Monday, April 13th. The shares were sold at an average price of $3.46, for a total transaction of $91,305.94. Following the sale, the insider...

Insider Selling: Whitehawk Therapeutics (NASDAQ:WHWK) Insider Sells 50,000 Shares of Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) insider Bryan Ball sold 50,000 shares of the firm's stock in a transaction on Thursday, April 9th. The shares were sold at an average...

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.09	--	--	N/A
Q4 '25	-$0.48	-$0.34	29.55%	BEAT
Q3 '25	-$0.51	-$0.26	49.02%	BEAT
Q2 '25	$0.82	-$0.76	-192.12%	MISSED
Q1 '25	--	$1.83	--	N/A

WHWK
Whitehawk Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest WHWK News

WHWKWhitehawk Therapeutics Inc.